The global protein detection and quantification market size is expected to reach USD 4.83 billion by 2030, expanding at a CAGR of 9.0% from 2024 to 2030. The introduction of assay methods that enable protein estimation at lower limits of concentration in order to monitor the changes is expected to drive growth in the coming years.
Governments are encouraging the research activities by raising funds in the field of proteomics industry and thus the protein detection and quantification market is anticipated to grow at a significant pace in the coming years. The presence of organizations such as the Human Proteome Organization, National Cancer Institute (NCI), and Genomic Health Inc. promotes funding to support R&D and product development exercises pertaining to the field of proteomics.
Growing need to understand chronic diseases at a molecular level and develop therapeutic solutions is expected to encourage these organizations to fund research and development programs. In addition, Public Health Genomics at the National Cancer Institute (NCI) promotes the integration of personalized medicine and genomics into public health cancer research in an attempt to reduce the burden of cancer across the globe
Although technological advancements continue to take place for simplification protein estimation, high cost of technology and assays are anticipated to restrict the usage of these assays and technologies under certain circumstances. For instance, Mass Spectroscopy (MS) which is often used for functional proteomics is considered expensive and slow by researchers. In targeted MS, custom antibodies are required for each target to perform immunoaffinity enrichment of peptides. This process is observed to be expensive as well as lengthy.
This product will be delivered within 1-3 business days.
Governments are encouraging the research activities by raising funds in the field of proteomics industry and thus the protein detection and quantification market is anticipated to grow at a significant pace in the coming years. The presence of organizations such as the Human Proteome Organization, National Cancer Institute (NCI), and Genomic Health Inc. promotes funding to support R&D and product development exercises pertaining to the field of proteomics.
Growing need to understand chronic diseases at a molecular level and develop therapeutic solutions is expected to encourage these organizations to fund research and development programs. In addition, Public Health Genomics at the National Cancer Institute (NCI) promotes the integration of personalized medicine and genomics into public health cancer research in an attempt to reduce the burden of cancer across the globe
Although technological advancements continue to take place for simplification protein estimation, high cost of technology and assays are anticipated to restrict the usage of these assays and technologies under certain circumstances. For instance, Mass Spectroscopy (MS) which is often used for functional proteomics is considered expensive and slow by researchers. In targeted MS, custom antibodies are required for each target to perform immunoaffinity enrichment of peptides. This process is observed to be expensive as well as lengthy.
Protein Detection And Quantification Market Report Highlights
- Colorimetry dominated with the largest share due to the presence of significant usage of the reagents and solutions for laboratory analysis
- Immunological methods and spectrometric methods are anticipated to grow at similar rates and exhibit the fastest Y-o-Y growth
- Advancements in these segments such as FTIR and SMCxPRO technology are attributive for the projected growth rate
- Consumables accounted for the largest share due to wider availability and usage of kits and reagents
- Clinical diagnosis is expected to register the fastest progress in the coming years as a result of rising adoption these methods
- Substantial use of technology in target identification and other steps of drug discovery is attributive for the largest share of drug discovery as an application of estimation of these biomolecules
- Academic organizations dominated with respect to use of these protocols and clinical diagnostic labs anticipated to witness the fastest progress
- North American region accounted for the largest share as a consequence of a large number of proteomics projects implemented herein
- Asia Pacific market is expected to grow at the most lucrative pace due to changing health care infrastructure in this region which drives the demand for these products
- These companies are engaged in collaborations, mergers & acquisitions for the new product launches that rely on conventional technology but provide the novel application in the field of proteomics
The leading players in the Protein Detection and Quantification market include:
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- General Electric Company
- Inanovate
- Merck KGaA
- PerkinElmer Inc.
- RayBiotech Life Inc.
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Protein Detection and Quantification Market Variables, Trends, and Scope
Chapter 4. Protein Detection and Quantification Market: Technology Estimates and Trend Analysis
Chapter 5. Protein Detection and Quantification Market: Product Estimates and Trend Analysis
Chapter 6. Protein Detection and Quantification Market: Application Estimates and Trend Analysis
Chapter 7. Protein Detection and Quantification Market: End Use Estimates and Trend Analysis
Chapter 8. Protein Detection and Quantification Market: Regional Estimates and Trend Analysis
Chapter 9. Competitive Landscape
Companies Mentioned
The leading players in the Protein Detection and Quantification market include:- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- General Electric Company
- Inanovate
- Merck KGaA
- PerkinElmer Inc.
- RayBiotech Life Inc.
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.68 Billion |
| Forecasted Market Value ( USD | $ 4.83 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
